Zobrazeno 1 - 10
of 109
pro vyhledávání: '"Serena Lembo"'
Autor:
Antonia Falco, Anna Basile, Annunziata Raimondo, Giulia Guglielmi, Alessandra Rosati, Margot De Marco, Maria Caterina Turco, Maria Pascale, Serena Lembo
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-2 (2024)
Externí odkaz:
https://doaj.org/article/737bf1c86f0148fabe171bbe816725fb
Publikováno v:
Dermatology Practical & Conceptual, Vol 14, Iss 2 (2024)
Introduction: the oral health in psoriatic patients seems to be compromised respect to control individuals: many published studies have investigated the relationship between psoriatic disease and gingivitis, periodontitis, and missing teeth. However,
Externí odkaz:
https://doaj.org/article/9327dadb6bcc40c3b2994de5a897eebb
Autor:
Cristina Pagano, Elena Ciaglia, Laura Coppola, Valentina Lopardo, Annunziata Raimondo, Monfrecola Giuseppe, Serena Lembo, Chiara Laezza, Maurizio Bifulco
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionThe involvement of endocannabinoid system (ECS) in the inflammatory cascade, and the ability of phytocannabinoids, endocannabinoids and their synthetic analogues to modulate it has become an interesting research area for new therapeutic a
Externí odkaz:
https://doaj.org/article/e65d5379fbff41428cf953f7f1a99e5a
Autor:
Matteo Megna, Anna Balato, Stefano Caccavale, Sara Cacciapuoti, Giulia Calabrese, Eugenia Veronica Di Brizzi, Luisa Di Costanzo, Raffaella Manzo, Vincenzo Marino, Rosa Valentina Puca, Francesca Romano, Oriele Sarno, Genoveffa Scotto di Luzio, Serena Lembo
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 9, p 2552 (2024)
Background: Guselkumab is the first approved human IgG1λ monoclonal antibody selectively targeting the p19 subunit of IL23. Its effectiveness and safety were widely reported by clinical trials. However, these results must be confirmed in real life s
Externí odkaz:
https://doaj.org/article/ffe1f768101d4e50a5ad9cd46f303545
Autor:
Federica Di Spirito, Annunziata Raimondo, Maria Pia Di Palo, Stefano Martina, Mario Fordellone, Donato Rosa, Massimo Amato, Serena Lembo
Publikováno v:
Life, Vol 14, Iss 3, p 347 (2024)
Psoriasis is a widespread chronic inflammatory skin disease, that negatively affects physical and emotional well-being and quality of life, as shown by the generally low Dermatology Life Quality Index (DLQI). Psoriasis is burdened by associated comor
Externí odkaz:
https://doaj.org/article/6d6ee22254f147bb970b07ad8b83f9a4
Autor:
Francesca Prignano, Giuseppe Argenziano, Federico Bardazzi, Riccardo G. Borroni, Alexandra M. G. Brunasso, Martina Burlando, Anna Elisabetta Cagni, Elena Campione, Elisa Cinotti, Fabrizio Colonna, Aldo Cuccia, Stefano Dastoli, Rocco De Pasquale, Clara De Simone, Vito Di Lernia, Valentina Dini, Gabriella Fabbrocini, Claudia Galluzzi, Alfredo Giacchetti, Claudia Giofrè, Claudia Lasagni, Serena Lembo, Francesco Loconsole, Maria Antonia Montesu, Paolo Pella, Stefano Piaserico, Paolo Pigatto, Antonio Giovanni Richetta, Adriana Scuotto, Elena Stroppiana, Marina Venturini, Anna Stefania Vinci, Leonardo Zichichi, Maria Concetta Fargnoli
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 1, p 101 (2023)
A nationwide cross-sectional online survey was administered to dermatologists managing patients with moderate-to-severe plaque psoriasis across Italy to obtain real-world dermatologists’ perspectives on the impact of psoriasis and its treatment on
Externí odkaz:
https://doaj.org/article/ab2bd7a3b4074791870ebc4e45390aa6
Autor:
Matteo Megna, Cataldo Patruno, Maria Rita Bongiorno, Alessio Gambardella, Claudio Guarneri, Caterina Foti, Serena Lembo, Francesco Loconsole, Gabriella Fabbrocini
Publikováno v:
Journal of Dermatological Treatment, Vol 33, Iss 5, Pp 2629-2633 (2022)
Background Some biologics for psoriasis, especially anti-tumor necrosis factor (TNF)-α therapies, may re-activate latent tuberculosis (TBC) infection with consequent morbidity and mortality. However, there is a low reported incidence of conversion t
Externí odkaz:
https://doaj.org/article/0ed66412602a44e5b24417f2bd1d52a1
Autor:
Maria Concetta Fargnoli, Federico Bardazzi, Luca Bianchi, Paolo Dapavo, Gabriella Fabbrocini, Paolo Gisondi, Giuseppe Micali, Anna Maria Offidani, Giovanni Pellacani, Nevena Skroza, Rosa Giuseppa Angileri, Martina Burlando, Anna Campanati, Carlo Giovanni Carrera, Andrea Chiricozzi, Andrea Conti, Clara De Simone, Vito Di Lernia, Enzo Errichetti, Marco Galluzzo, Claudio Guarneri, Claudia Lasagni, Serena Lembo, Francesco Loconsole, Matteo Megna, Maria Letizia Musumeci, Francesca Prignano, Antonio Giovanni Richetta, Emanuele Trovato, Marina Venturini, Ketty Peris, Piergiacomo Calzavara Pinton
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 10, p 3545 (2023)
Brodalumab is a recombinant, fully human immunoglobulin IgG2 monoclonal antibody specifically targeted against interleukin-17RA that has been approved for the treatment of moderate-to-severe psoriasis in Europe. We developed a Delphi consensus docume
Externí odkaz:
https://doaj.org/article/13c25ad0b36d4777a9b28ce339de0788
Autor:
Annunziata Raimondo, MD, Giulia Guglielmi, MD, Carlo Marino, MD, Luigi Ligrone, MD, Serena Lembo, MD, PhD
Publikováno v:
JAAD Case Reports, Vol 11, Iss , Pp 51-53 (2021)
Externí odkaz:
https://doaj.org/article/5e32cb9bf2f540ff8c3afb7f659beb15
Autor:
Annunziata Raimondo, Serena Lembo
Publikováno v:
Dermatology Practical & Conceptual (2021)
Atopic dermatitis (AD) is a chronic, lifelong, relapsing condition. The wide spectrum of the possible clinical presentations, depending on patient’s age, age of onset of disease, topography and morphology of dermatitis, limits the epidemiologic inf
Externí odkaz:
https://doaj.org/article/ae3f6e053b934ea699f7b5e810e632b5